Suicide Risk and Symptom Reduction in Patients Assigned to Placebo in Duloxetine and Escitalopram Clinical Trials: Analysis of the FDA Summary Basis of Approval Reports

By Khan Arif   Schwartz Kelly  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 1, 2007-01 ,pp. : 31-36

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials

By D’Amico Domenico  

Neurological Sciences, Vol. 31, Iss. 1, 2010-06 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

Testosterone gel supplementation for men with refractory depression: a randomized placebo-controlled trial

By Pope H.   Cohane G.   Kanayama G.   Siegel A.   Hudson J.  

Journal of Psychosomatic Research, Vol. 55, Iss. 2, 2003-08 ,pp. : 134-134

Elsevier

Access to resources Recommend Favorite

Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trial

By Wermuth L.   Sørensen P. S.   Timm S.   Christensen B.   Utzon N. P.   Boas J.   Dupont E.   Hansen E.   Magnussen I.   Mikkelsen B.   Worm-Petersen J.   Lauritzen L.   Bayer L.   Bech P.  

Nordic Journal of Psychiatry, Vol. 52, Iss. 2, 1998-07 ,pp. : 163-169

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsant therapy in the elderly--A need for placebo controlled trials

By Cameron H.   Macphee G.J.A.  

Epilepsy Research, Vol. 21, Iss. 2, 1995-06 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite